Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysisDiabetes Obes Metab 2023 Jul 12;[EPub Ahead of Print], I Avgerinos, T Karagiannis, DR Matthews, A Tsapas, E Bekiari
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.